These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 2608920
1. Radiation therapy of carcinoma of the oropharynx. Sakata K, Akanuma A, Aoki Y, Nakagawa K, Karasawa K, Iio M. Radiat Med; 1989; 7(4):189-92. PubMed ID: 2608920 [Abstract] [Full Text] [Related]
2. [Prognostic factors and results of external irradiation of cancers of the base of the tongue]. Jaulerry C, Bataini JP, Brunin F, Rodriguez J, Brugère J. Ann Otolaryngol Chir Cervicofac; 1985; 102(7):519-24. PubMed ID: 3937474 [Abstract] [Full Text] [Related]
3. Radiation therapy for early-stage carcinoma of the oropharynx. Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):743-51. PubMed ID: 15183477 [Abstract] [Full Text] [Related]
4. Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy. Johansen LV, Overgaard J, Overgaard M, Birkler N, Fisker A. Laryngoscope; 1990 Sep 01; 100(9):985-90. PubMed ID: 2395408 [Abstract] [Full Text] [Related]
6. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Moncrieff M, Sandilla J, Clark J, Clifford A, Shannon K, Gao K, O'Brien C. Laryngoscope; 2009 Feb 01; 119(2):307-11. PubMed ID: 19172611 [Abstract] [Full Text] [Related]
7. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW. Ai Zheng; 2006 Nov 01; 25(11):1419-22. PubMed ID: 17094913 [Abstract] [Full Text] [Related]
8. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx. Pericot J, Escribà JM, Valdés A, Biosca MJ, Monner A, Castellsagué X, Galiana R, Piulachs P, Escutia E, Mari A. J Craniomaxillofac Surg; 2000 Feb 01; 28(1):49-55. PubMed ID: 10851674 [Abstract] [Full Text] [Related]
9. [Topometric and clinico-dosimetric aspects of the radiotherapy of cancer of the oropharynx]. Choudkhuri FA, Vorob'eva LV. Med Radiol (Mosk); 1988 Mar 01; 33(3):38-45. PubMed ID: 3352492 [Abstract] [Full Text] [Related]
10. Definition of iso-effective dosage according to the alpha-beta-model for a squamous carcinoma of the head-and-neck region. Wagner W. Strahlenther Onkol; 1989 Jul 01; 165(7):518-9. PubMed ID: 2749487 [No Abstract] [Full Text] [Related]
11. [Results of radiotherapy in advanced oropharyngeal carcinomas. Primary and postoperative radiotherapy versus radiotherapy following polychemotherapy]. Flentje M, Mende U, Weischedel U, Wieland C. Strahlenther Onkol; 1988 Feb 01; 164(2):68-72. PubMed ID: 3344480 [Abstract] [Full Text] [Related]
12. Prognostic factor of radiotherapy for squamous cell carcinoma of oropharynx without clinically positive nodes. Inoue T, Inoue T, Ikeda H, Teshima T, Murayama S, Yamazaki H, Otani M. Strahlenther Onkol; 1993 Aug 01; 169(8):476-80. PubMed ID: 8356506 [Abstract] [Full Text] [Related]
13. [Assessment of different variants of hyperfractionated irradiation in cancer of the naso- and oropharynx and of the oral mucosa]. Aliev BM, Chuprik-Malinovskaia TP, Aleknavichius EE. Med Radiol (Mosk); 1988 Jun 01; 33(6):37-41. PubMed ID: 3386429 [Abstract] [Full Text] [Related]
17. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Layland MK, Sessions DG, Lenox J. Laryngoscope; 2005 Apr 01; 115(4):629-39. PubMed ID: 15805872 [Abstract] [Full Text] [Related]